The findings indicated that ITGB1, which was markedly increased in HCC tumors compared to normal tissues, was also progressively upregulated along with clinical stages of HCC patients from I to IV (Figure 1A, B). This evidence concerns the gene ITGB1 and hepatocellular carcinoma.